太极集团：全资子公司收到药物临床试验批准通知书

Core Viewpoint - Taiji Group's wholly-owned subsidiary has received approval for clinical trials of Semaglutide injection from the National Medical Products Administration [1] Group 1 - Taiji Group announced on the evening of September 9 that its subsidiary, Taiji Group Chongqing Fuling Pharmaceutical Factory Co., Ltd., has received the "Drug Clinical Trial Approval Notice" for Semaglutide injection [1]